win 56291 has been researched along with win 54954 in 2 studies
Studies (win 56291) | Trials (win 56291) | Recent Studies (post-2010) (win 56291) | Studies (win 54954) | Trials (win 54954) | Recent Studies (post-2010) (win 54954) |
---|---|---|---|---|---|
5 | 0 | 1 | 24 | 2 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chapman, MS; Diana, GD; Dutko, FJ; Kim, KH; Mallamo, JP; Minor, I; Oliveira, M; Pevear, DC; Rossmann, MG | 1 |
Andries, K; Chapman, MS; Diana, GD; Gong, ZX; Kim, KH; Kremer, MJ; Minor, I; Oliveira, MA; Rossmann, MG; Willingmann, P | 1 |
2 other study(ies) available for win 56291 and win 54954
Article | Year |
---|---|
Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A.
Topics: Antiviral Agents; Binding Sites; Humans; Isoxazoles; Models, Molecular; Rhinovirus; Structure-Activity Relationship | 1992 |
A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Capsid; Conserved Sequence; Drug Design; Isoxazoles; Models, Molecular; Molecular Sequence Data; Pyridazines; Rhinovirus; Sequence Alignment; Serotyping; Structure-Activity Relationship | 1993 |